Literature DB >> 10893371

Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study.

B Afessa1, B Green.   

Abstract

STUDY
OBJECTIVE: To describe the clinical course and prognostic factors in patients with HIV admitted to the ICU.
DESIGN: Prospective, observational.
SETTING: A university-affiliated medical center.
METHODS: : We included 169 consecutive ICU admissions, from April 1995 through March 1999, of 141 adults with HIV. Data collected included APACHE (acute physiology and chronic health evaluation) II score, CD4(+) lymphocyte count, serum albumin level, in-hospital mortality, and the development of organ failure, systemic inflammatory response syndrome (SIRS), and ARDS.
RESULTS: The ICU admission rate of hospitalized patients with HIV infection was 12%. The most common reason for ICU admission was respiratory failure, occurring in 65 patient admissions. Mechanical ventilation was required in 91 admissions (54%), ARDS developed in 37 admissions (22%), Pneumocystis carinii pneumonia was diagnosed in 24 admissions (14%), and SIRS developed in 126 admissions (75%). One or more organ failures developed in 131 admissions (78%). The actual and predicted mortality rates were 29.6% and 45.2%, respectively, with a standardized mortality ratio of 0.65. The most frequent immediate cause of death was bacterial infection. The CD4(+) lymphocyte count (median, 27.5 cells/microL vs 59 cells/microL; p = 0.0310) and serum albumin level (median 2.2 g/dL vs 2.6 g/dL; p = 0.0355) of nonsurvivors were lower and the APACHE II score (median, 30 vs 21; p < 0.0001) was higher, compared to those of survivors. A higher APACHE II score (odds ratio [OR], 1.11; 95% confidence interval [CI], 1.05 to 1.16) and a transfer from another hospital ward (OR, 3.03; 95% CI, 1.20 to 7.68) were independently associated with increased mortality. The median number of organ failures that developed in survivors was one, compared to four in nonsurvivors (p < 0.0001).
CONCLUSIONS: The outcome of HIV-infected patients admitted to the ICU has improved over the years. The CD4 count does not correlate with in-hospital mortality. Higher APACHE II scores and a transfer from another hospital ward are associated with a poor outcome.

Entities:  

Mesh:

Year:  2000        PMID: 10893371     DOI: 10.1378/chest.118.1.138

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  31 in total

Review 1.  The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia.

Authors:  R J Boyton; D M Mitchell; O M Kon
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

2.  Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.

Authors:  Denise L Jacobson; Donna Spiegelman; Tamsin K Knox; Ira B Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

3.  [Treatment of neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome].

Authors:  O Braicks; K Anneken; D Reichelt; W R Schäbitz; R Dziewas; S Evers; I W Husstedt
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

4.  Comparing outcomes of HIV versus non-HIV patients requiring mechanical ventilation.

Authors:  Vikas Pathak; Iliana Samara Hurtado Rendon; Shebli Atrash; Vinay Prasad Rao Gagadam; Kaushik Bhunia; Syam Prasad Mallampalli; Vijay Vegesna; Mahesh Mani Dangal; Ronald L Ciubotaru
Journal:  Clin Med Res       Date:  2011-10-26

Review 5.  Critical illness in HIV-infected patients in the era of combination antiretroviral therapy.

Authors:  Kathleen M Akgün; Laurence Huang; Alison Morris; Amy C Justice; Margaret Pisani; Kristina Crothers
Journal:  Proc Am Thorac Soc       Date:  2011-06

6.  Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.

Authors:  Isaline Coquet; Juliette Pavie; Pierre Palmer; François Barbier; Stéphane Legriel; Julien Mayaux; Jean Michel Molina; Benoît Schlemmer; Elie Azoulay
Journal:  Crit Care       Date:  2010-06-09       Impact factor: 9.097

7.  Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients.

Authors:  André M Japiassú; Rodrigo T Amâncio; Emerson C Mesquita; Denise M Medeiros; Helena B Bernal; Estevão P Nunes; Paula M Luz; Beatriz Grinsztejn; Fernando A Bozza
Journal:  Crit Care       Date:  2010-08-10       Impact factor: 9.097

8.  Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.

Authors:  Benoît Vincent; Jean-François Timsit; Marc Auburtin; Frédérique Schortgen; Lila Bouadma; Michel Wolff; Bernard Regnier
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

9.  Detection of Helicobacter pylori, Enterococcus faecalis, and Pseudomonas aeruginosa in the subgingival biofilm of HIV-infected subjects undergoing HAART with chronic periodontitis.

Authors:  L de Souza Gonçalves; R Souto; A P V Colombo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-07-29       Impact factor: 3.267

10.  Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit.

Authors:  Julio Croda; Mariana Garcia Croda; Alan Neves; Sigrid De Sousa dos Santos
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.